Search clinical trials for: SPF 15 V27 104 (BAY987519)

Total 230 results

Bayer

Completed

To Test for Photo Allergy Reaction of Sunscreens

Photoallergy

United States
Bayer

Completed

Test the Phototoxicity of Sunscreen Products

Sunscreen Agents

United States
Bayer

Completed

Sun Protection Factor (SPF) Efficacy Assay

Sunscreen Agents

United States
Bayer

Completed

Sun Protection Factor Assay (339/2016)

Sunscreening Agents

United States
Bayer

Terminated

Sun Protection Factor Assay (318/2016) (SPF Assay)

Sunscreening Agents

United States
University of Oslo

Completed

Efficiency of a Jellyfish Sting Inhibitor Sun Lotion and Protocols for Jellyfish Sting Pain Relief

Pain

Norway
Bayer

Completed

Sun Protection Factor Assay (341/2016)

Sunscreening Agents

United States
Bayer

Completed

Sun Protection Factor Assay (338/2016)

Sunscreening Agents

United States
Bayer

Completed

Sun Protection Factor Assay (317/2016) (SPF Assay)

Sunscreening Agents

United States
Bayer

Terminated

Sun Protection Factor Assay (319/2016) (SPF Assay)

Sunscreening Agents

United States
Bayer

Completed

Sun Protection Factor Assay (343/2016)

Sunscreening Agents

United States
Bayer

Completed

Sun Protection Factor Assay (344/2016)

Sunscreening Agents

United States
Bayer

Completed

Sun Protection Factor (SPF) Assay

Sunscreen Agents

United States
Bayer

Completed

Sun Protection Factor (SPF) / UVA Protection Factor (UVAPF) - Assay

Sunscreen Agents

United States
Bayer

Completed

Sun Protection Factor (SPF) - Static and Water Resistant Assay

Sunscreen Agents

United States
Bayer

Completed

Sun Protection Factor (SPF) / UVA Protection Factor (UVAPF) Assay

Sunscreen Agents

United States
Sun Protection Foundation

Enrolling by invitation

Natural Sunlight Protection and Simulated Sunlight Protection Offered by Sunscreens and Fabrics

Sunburn | Sun Damaged Skin | Overexposure to Sun Rays

United States, Chile, Peru
UCB Pharma

Completed

A Trial to Assess the Efficacy and Safety of SPM 927 in Subjects With Painful Distal Diabetic Neuropathy

Diabetic Neuropathy

United States
UCB Pharma

Completed

A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Trial to Investigate the Efficacy and Safety of SPM 927 (200mg/Day and 400mg/Day) as Adjunctive Therapy in Subjects With Partial Seizures With or Without Secondary Generalization

Partial Seizures With or Without Secondary Generalization

Germany
UCB Pharma

Completed

SPM 927 (400mg/Day and 600mg/Day) as Adjunctive Therapy in Subjects With Partial Seizures With or Without Secondary Generalization

Epilepsy
UCB Pharma

Completed

Trial to Assess the Efficacy and Safety of SPM 927 (200, 400, and 600mg/Day) in Subjects With Painful Distal Diabetic Neuropathy

Diabetic Neuropathies

United States
UCB Pharma

Completed

Safety and Tolerability of Intravenous SPM 927 as Replacement for Oral SPM 927 in Subjects With Partial Seizures

Epilepsies, Partial

United States
Bayer

Completed

Evaluation of the Stinging Potential of Sunscreen Products in Human Eyes

Sunscreen Agents

United States
Bayer

Completed

Evaluation of a Gel Sunscreen in Controlled Use Conditions (208/2016)

Sunscreening Agents

United States
UCB Pharma

Completed

An Open-Label Follow-on Trial to Assess the Long-Term Safety and Efficacy of Oral SPM 927 in Subjects With Postherpetic Neuralgia (PHN)

Postherpetic Neuralgia

Germany
N-Gene Research Laboratories, Inc.
Thermo Fisher Scientific, Inc; Integrium; Msource Medical Development GmbH; Kinexum... and other collaborators

Terminated

Safety and Efficacy of BGP-15 in Patients With Type 2 Diabetes Mellitus

Diabetes Mellitus

United States, Germany, Hungary
The University of Hong Kong

Completed

Effect of Application Time of 38% Silver Diamine Fluoride Solution on Arresting Dental Caries in Preschool Childre

Early Childhood Caries

Hong Kong
AcelRx Pharmaceuticals, Inc.

Completed

Single and Multiple Dose Pharmacokinetics of Sufentanil NanoTab

Plasma Concentrations

United States
UCB Pharma

Completed

A Trial to Investigate the Safety, Tolerability and Pharmacokinetics of Intravenous SPM 927

Epilepsy
Protalex, Inc.

Terminated

PRTX-100-202 Open-Label, Dose Escalation Study in Adult Patients With ITP

Immune Thrombocytopenia

United States, United Kingdom
Protalex, Inc.

Terminated

PRTX-100-203 Open-Label, Dose Escalation Study in Adult Patients With ITP

Immune Thrombocytopenia

France, United Kingdom
Juventas Therapeutics, Inc.

Unknown

Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure. (STOP-HF)

Ischemic Heart Failure

United States
UCB Pharma

Completed

A Trial to Assess the Efficacy and Safety of SPM 927 (Lacosamide) in Subjects With Painful Distal Diabetic Neuropathy

Diabetic Neuropathy

Germany
Bayer

Completed

Evaluation of the Irritation Potential of Products in Human Eyes

Sunscreening Agents

United States
University Hospital, Bordeaux

Completed

Multi-disciplinary Prevention Program (4P-ED)

Stroke

France
UCB Pharma
SCHWARZ BIOSCIENCES GmbH - Part of UCB Group

Completed

A Trial to Assess the Long-term Safety and Efficacy of Lacosamide in Subjects With Painful Diabetic Neuropathy

Painful Diabetic Neuropathy

Germany
National Institute of Allergy and Infectious Diseases...
ImmunityBio, Inc.; Rockefeller University

Recruiting

Safety, Tolerability, and Efficacy of IL-15 Superagonist (N-803) With and Without Combination Broadly Neutralizing Antibodies to Induce HIV-1 Control During Analytic Treatment Interruption

HIV Infection

United States
Medical University of Vienna

Completed

Effect of Systemic Hypoxia and Hyperoxia on Retinal Oxygen Saturation

Retinal Blood Flow | Retinal Oxygenation

Austria
Pfizer

Terminated

Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients With Motor Fluctuations

Parkinson's Disease With Motor Fluctuations

United States
Protalex, Inc.

Completed

6-Month Phase I/II Open Label PRTX-100 in Previous Rheumatoid Arthritis Study Participants and Sera Collection (SPARTA-II)

Arthritis, Rheumatoid

United States
Bausch Health Americas, Inc.

Terminated

AMG 827 in Subjects With Psoriatic Arthritis

Psoriatic Arthritis

United States, Canada
Aalborg University

Completed

Characterization of New Human Models of Non-histaminergic Itch

Itch | Papain | Skin Prick Test (SPT)

Denmark
AcelRx Pharmaceuticals, Inc.

Completed

Effect of Ketoconazole on Sufentanil NanoTab Pharmacokinetics

Pharmacokinetics

United States
SparX Biotech(Jiangsu) Co., Ltd.

Not yet recruiting

Study of SPX-101 in Subjects With Advanced or Refractory Solid Tumors

Solid Tumors
Scilex Pharmaceuticals, Inc.
Worldwide Clinical Trials; Semnur Pharmaceuticals, Inc.

Completed

Corticosteroid Lumbar Epidural Analgesia for Radiculopathy

Lumbosacral Radicular Pain

United States
Splash Pharmaceuticals, Inc.

Unknown

Safety and Efficacy Study of Daily SPL-108 Injections In Conjunction With Paclitaxel in Women With Ovarian Cancer

Ovarian Epithelial Cancer

United States
Spyryx Biosciences, Inc.

Completed

A Safety Study of SPX-101 Inhalation Solution in Subjects With Cystic Fibrosis

Cystic Fibrosis

Canada
Pfizer

Completed

STUDY TO COMPARE PHARMACOKINETICS (PK) OF SINGLE ORAL DOSES OF DIFFERENT PF-06882961 FORMULATIONS IN PARTICIPANTS WHO ARE OVERWEIGHT OR HAVE OBESITY

Overweight and/or Obesity

Belgium
Spyryx Biosciences, Inc.

Completed

An Efficacy and Safety Study of SPX-101 Inhalation Solution in Subjects With Cystic Fibrosis ((HOPE-1))

Cystic Fibrosis

United Kingdom, Canada, France, Italy, Portugal
Pfizer

Recruiting

A Study to Learn About the Study Medicine Called PF-07799544 in People With Advanced Solid Tumors

Glioma | Melanoma | Colorectal Cancer | Brain Neoplasms | Non-Small Cell Lung Cancer | Thyroid Cancer | Malignant Neoplasms

Canada, United States

3

Subscribe